YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
This article first appeared on GuruFocus. Release Date: September 22, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points PureTech Health PLC ended H1 2026 with $220 mil…
Key Points Interested in PureTech Health PLC Sponsored ADR? Here are five stocks we like better. PureTech reported $220 million in cash and short-term investments at the parent-company level and expects its operational runway to last throu…
BOSTON, August 31, 2026--(BUSINESS WIRE)--Seaport Therapeutics, Inc. (Nasdaq: SPTX) ("Seaport" or the "Company"), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced that…
Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled…
Quick Read SPTX's Glyph prodrug platform has generated 24 candidates, with lead asset GlyphAllo entering Phase 2b for MDD and topline results expected in 1H 2027. BMY previously paid $14 billion for Karuna Therapeutics, co-founded by Seapo…
(RTTNews) - Seaport Therapeutics, Inc. (SPTX), reported a wider net loss for its first financial quarter ended March 31, 2026, and provided near term milestone update. Company Profile Seaport Therapeutics is a clinical-stage therapeutics c…
New data from Phase 1 trial of GlyphAgoTM build upon previously reported topline data and further demonstrate GlyphAgoTM can achieve therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or eli…
[Business Stock Exchange Trading Concepts] Rawpixel Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY…
aprott/iStock via Getty Images Shares of Hemab Therapeutics (COAG [https://seekingalpha.com/symbol/COAG]) and Seaport Therapeutics (SPTX [https://seekingalpha.com/symbol/SPTX]) surged on Friday as the clinical-stage biotechs made their tra…
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO Proactive uses images sourced from Shutterstock PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Th…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Blood disease specialist Hemab Therapeutics and brain drug developer Seaport Therapeutics bot…
(Bloomberg) -- Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise $212.4 million in a US initial public offering. Most Read from Bloomberg Sergey Brin Confron…
Worawith Ounpeng Seaport Therapeutics (SPTX [https://seekingalpha.com/symbol/SPTX]), a clinical-stage biotech focused on developing drugs for neuropsychiatric diseases such as depression, has submitted regulatory filings to the SEC for its…